Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Misonix Inc. (MSON) -- Ignore unavailable to you. Want to Upgrade?

To: cape radical who wrote (841)	11/2/1998 8:06:00 PM
From: Candle stick	Read Replies (2) \| Respond to of 947

Misonix, Inc. Announces McManus as New Chief Executive Officer FARMINGDALE, N.Y.--(BUSINESS WIRE)--Nov. 2, 1998--Misonix, Inc. ("Misonix") (Nasdaq: MSON) today announced that Michael A. McManus, Jr. has been appointed as its new President and Chief Executive Officer, commencing November 2, 1998. Mr. McManus has been a Director of the Company since September, 1998. He has had substantial experience in the areas of law, government, acquisitions, healthcare and banking. He was most recently President and Chief Executive Officer of New York Bancorp., a New York Stock Exchange company that was one of the highest returning thrifts in the country. He was responsible for growing that company from approximately $900 million to $3.2 billion prior to its sale in March 1998. Prior to New York Bancorp, Mr. McManus had served as Corporate Counsel and then as a Vice President of Strategic Planning at Pfizer Inc., the major healthcare company. From 1982 to 1985, he served as an Assistant to President Reagan in the White House where he was responsible for planning and special projects. In 1985, he was an Executive Vice President of MacAndrews and Forbes where he worked on the acquisitions of Pantry Pride and Revlon. Mr. McManus holds a B.A. in Economics from the University of Notre Dame and a J.D. from the Georgetown Law Center. He serves on the Board of Directors of the United States Olympic Committee, among others. Mr. McManus succeeds Dr. Joseph Librizzi who will continue as a special consultant and advisor to Misonix for the next six (6) months to assist in providing for an orderly transition. Gary Gelman, Chairman of Misonix, noted: "Mr. McManus, with his leadership talents and broad experience, especially in the medical and financial fields, is an ideal choice to lead the Company. We are delighted to have him aboard." Misonix, Inc. develops, manufactures, and/or markets medical, scientific, and industrial ultrasonic and air pollution systems. Forward Looking Statements: Statements in this news release looking forward in time are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties, including general economic conditions, delays and risks associated with the performance of contracts, potential acquisitions, consumer and industry acceptance, litigation and regulatory risks. CONTACT: Peter Gerstheimer Vice President and CFO Misonix, Inc. (516) 694-9555 To edit your profile, go to keyword NewsProfiles. For all of today's news, go to keyword News